...
search icon
dvax-img

Dynavax Technologies Corporation, Common Stock

DVAX

NSQ

$9.62

-$0.23

(-2.34%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.31B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.74M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.26
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$9.28 L
$14.63 H
$9.62

About Dynavax Technologies Corporation, Common Stock

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Epidemic Preparedness Innovations; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; and Biological E. Limited. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameDVAXSectorS&P500
1-Week Return-11.9%1.21%4.35%
1-Month Return-15.91%-1.86%8.16%
3-Month Return-24.19%-7.12%-4.41%
6-Month Return-28.85%-7.4%-2.39%
1-Year Return-12.78%-5.22%11.94%
3-Year Return0.21%5.72%45.17%
5-Year Return156.53%38.03%107.13%
10-Year Return-52.26%85.99%178.37%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue46.55M439.44M722.68M232.28M277.25M[{"date":"2020-12-31","value":6.44,"profit":true},{"date":"2021-12-31","value":60.81,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.14,"profit":true},{"date":"2024-12-31","value":38.36,"profit":true}]
Cost of Revenue13.91M173.57M262.15M50.17M49.45M[{"date":"2020-12-31","value":5.31,"profit":true},{"date":"2021-12-31","value":66.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":19.14,"profit":true},{"date":"2024-12-31","value":18.86,"profit":true}]
Gross Profit32.64M265.87M460.53M182.12M227.80M[{"date":"2020-12-31","value":7.09,"profit":true},{"date":"2021-12-31","value":57.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":39.55,"profit":true},{"date":"2024-12-31","value":49.46,"profit":true}]
Gross Margin70.12%60.50%63.73%78.40%82.17%[{"date":"2020-12-31","value":85.34,"profit":true},{"date":"2021-12-31","value":73.63,"profit":true},{"date":"2022-12-31","value":77.56,"profit":true},{"date":"2023-12-31","value":95.42,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses107.86M132.38M178.01M219.15M231.92M[{"date":"2020-12-31","value":46.51,"profit":true},{"date":"2021-12-31","value":57.08,"profit":true},{"date":"2022-12-31","value":76.75,"profit":true},{"date":"2023-12-31","value":94.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(75.22M)134.49M283.52M(37.03M)(4.12M)[{"date":"2020-12-31","value":-26.53,"profit":false},{"date":"2021-12-31","value":47.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-13.06,"profit":false},{"date":"2024-12-31","value":-1.45,"profit":false}]
Total Non-Operating Income/Expense(24.67M)(68.00M)11.96M52.66M64.65M[{"date":"2020-12-31","value":-38.16,"profit":false},{"date":"2021-12-31","value":-105.19,"profit":false},{"date":"2022-12-31","value":18.5,"profit":true},{"date":"2023-12-31","value":81.47,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(75.24M)77.52M294.30M(4.37M)30.86M[{"date":"2020-12-31","value":-25.57,"profit":false},{"date":"2021-12-31","value":26.34,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.48,"profit":false},{"date":"2024-12-31","value":10.48,"profit":true}]
Income Taxes16.54M808.00K1.14M2.02M3.55M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":4.89,"profit":true},{"date":"2022-12-31","value":6.91,"profit":true},{"date":"2023-12-31","value":12.23,"profit":true},{"date":"2024-12-31","value":21.44,"profit":true}]
Income After Taxes(91.78M)76.71M293.16M(6.39M)27.31M[{"date":"2020-12-31","value":-31.31,"profit":false},{"date":"2021-12-31","value":26.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.18,"profit":false},{"date":"2024-12-31","value":9.32,"profit":true}]
Income From Continuous Operations(82.95M)76.71M293.16M61.12M27.31M[{"date":"2020-12-31","value":-28.29,"profit":false},{"date":"2021-12-31","value":26.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":20.85,"profit":true},{"date":"2024-12-31","value":9.32,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(91.78M)76.71M293.16M(6.39M)27.31M[{"date":"2020-12-31","value":-31.31,"profit":false},{"date":"2021-12-31","value":26.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.18,"profit":false},{"date":"2024-12-31","value":9.32,"profit":true}]
EPS (Diluted)(0.84)0.341.97(0.06)0.18[{"date":"2020-12-31","value":-42.64,"profit":false},{"date":"2021-12-31","value":17.26,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.96,"profit":false},{"date":"2024-12-31","value":9.14,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DVAX
Current Ratio 11.93
Quick Ratio 10.84

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DVAX
ROA (LTM) -0.07%
ROE (LTM) -10.45%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DVAX
Debt Ratio Lower is generally better. Negative is bad. 0.44
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.56

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DVAX
Trailing PE NM
Forward PE 26.88
P/S (TTM) 3.92
P/B 2.13
Price/FCF NM
EV/R 2.56
EV/Ebitda 30.92
PEG NM

FAQs

What is Dynavax Technologies Corporation share price today?

Dynavax Technologies Corporation (DVAX) share price today is $9.62

Can Indians buy Dynavax Technologies Corporation shares?

Yes, Indians can buy shares of Dynavax Technologies Corporation (DVAX) on Vested. To buy Dynavax Technologies Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DVAX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Dynavax Technologies Corporation be purchased?

Yes, you can purchase fractional shares of Dynavax Technologies Corporation (DVAX) via the Vested app. You can start investing in Dynavax Technologies Corporation (DVAX) with a minimum investment of $1.

How to invest in Dynavax Technologies Corporation shares from India?

You can invest in shares of Dynavax Technologies Corporation (DVAX) via Vested in three simple steps:

  • Click on Sign Up or Invest in DVAX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Dynavax Technologies Corporation shares
What is Dynavax Technologies Corporation 52-week high and low stock price?

The 52-week high price of Dynavax Technologies Corporation (DVAX) is $14.63. The 52-week low price of Dynavax Technologies Corporation (DVAX) is $9.28.

What is Dynavax Technologies Corporation price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Dynavax Technologies Corporation (DVAX) is 2.13

What is the Market Cap of Dynavax Technologies Corporation?

The market capitalization of Dynavax Technologies Corporation (DVAX) is $1.31B

What is Dynavax Technologies Corporation’s stock symbol?

The stock symbol (or ticker) of Dynavax Technologies Corporation is DVAX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top